Effectiveness and Completion of Standardized Ketamine Infusion Protocol for Chronic Refractory Pain
In a study published in Regional Anesthesia & Pain Medicine, researchers evaluated a standardized low-dose ketamine infusion therapy (KIT) protocol for adults with chronic refractory pain. Among 1,034 patients, treatment completion was high (86%), with no serious adverse events reported. Patients experienced sustained improvements in physical and mental health up to six months post-treatment, highlighting the potential role of standardized KIT protocols within comprehensive, multidisciplinary pain care.
Interested in learning more about prescribing ketamine? CAPC's virtual workshop, Prescribing Ketamine for Symptom Management in Patients with Serious Illness, offers a comprehensive and practical overview of ketamine use in palliative care, with a focus on managing refractory pain and treatment-resistant depression in patients with serious illness. Space is limited. Register now.